Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 5, 2026

B2B Payments Global Report 2025: A 15.88 Trillion Market by 2030 from $11.69 Trillion in 2024 with Citi TTS, JP Morgan, HSBC Global, Visa, and Mastercard Accounting for 29.2% Share

View original at finance.yahoo.com
B2B Payments Global Report 2025: A 15.88 Trillion Market by 2030 from $11.69 Trillion in 2024 with Citi TTS, JP Morgan, HSBC Global, Visa, and Mastercard Accounting for 29.2% Share Company Logo Open Banking, AI/ML, and digital finance platforms are transforming B2B payments…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The continued digitization of enterprise finance and expansion of scalable payment infrastructure are expected to sustain long-term growth in the B2B payments market

    80% confidence

  • The B2B payments market will grow at a CAGR of 5.2% from 2024 to 2030

    80% confidence

  • Asia-Pacific and Latin America are the fastest-growing regions during the forecast period

    80% confidence

  • Citi TTS, JP Morgan, HSBC Global, Visa, and Mastercard together accounted for 29.2% of total market revenue in 2024

    80% confidence

  • SMEs are emerging as a key growth engine for the B2B payments market, particularly in regions with developing financial infrastructure

    80% confidence

  • North America and Europe accounted for the largest share of global B2B payments value in 2024

    80% confidence

  • The B2B payments market is projected to reach USD 15.88 trillion by 2030

    80% confidence

  • There are 61 major B2B payments providers globally

    80% confidence

  • The global B2B payments market was valued at USD 11.69 trillion in 2024

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com